SOHM Inc (OT:SHMN) Stock On Watchlist After Latest Development
This morning investors are expected to look into those stocks which may have come into focus yesterday and hence, the SOHM Inc (OT:SHMN) stock could be in play today. Here’s a quick look at the announcement from the company on Tuesday.
Important Appointment
The company hit the news wires yesterday after it announced that it appointed a new Senior Product Development Advisor in the form of Dr. David Zarling. The appointment went into effect immediately. In the news release, SOHM stated that Dr. Zarling boasted of considerable knowledge and expertise that could help the company in the marketing, development and sales of new offerings. The new offerings will be in the neutraceuticals and pharmaceuticals categories; however ABBIE technology products would also be in the mix.
Credentials
Dr. Zarling holds considerable experience in Senior Advisory roles through the course of his career and that was highlighted by the company in the news release. Additionally, he also has significant experience in senior level experience in product leadership and strategic partnering in the realms of pharmaceuticals, medical devices, healthcare, companion diagnostics and biotechnology among others.
It was also highlighted that during the course of his distinguished career Dr. Zarling had also been instrumental in identifying strategic partnerships and opportunities in the pharmaceutical and biotech industries. Such initiatives led to strong revenue generation as well.
Traders Notes
Technicals
| +/- EMA(20) | 0.0011 (-9.09%) |
| +/- SMA(50) | 0.0011 (-9.09%) |
| +/- SMA(200) | 0.0013 (-23.08%) |
| 5-Day Perf. | -16.67% |
| 1-Month Perf. | -16.67% |
| 3-Month Perf. | +11.11% |
| 6-Month Perf. | -41.18% |
| YTD Perf. | -28.57% |
| 1-Year Perf. | -9.09% |
| RSI(14) | 31.97 |
| ATR(14) | – |
| ADX(14) | 30.66 |
